1 / 4

Melanoma Cancer Market Trends, Size, Competitive Analysis and Forecast 2021-2027

The global market for melanoma cancer is projected to have a considerable CAGR of around 12.3% during the forecast period. Melanoma is a skin cancer that develops in the melanocyte cells, responsible for producing melanin, a pigment that gives color to the skin. It is the most serious type of skin cancer and it seems to be increasing in people under 40, especially women.

Meenoo
Download Presentation

Melanoma Cancer Market Trends, Size, Competitive Analysis and Forecast 2021-2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Melanoma Cancer Market, Size, Share, Analysis Report & Forecast to 2027 To Market: https://www.omrglobal.com/request-sample/melanoma-cancer-market Request a Sample of our Report on Melanoma Cancer Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. The global melanoma cancer market global melanoma cancer market is anticipated to grow at a CAGR of around 12.3% during the forecast period (2021-2027). The factor propelling the growth of the market include the rise in the number of FDA approvals for melanoma cancer drugs/systems produced by key market players. For instance, in July 2021, Genentech, a subsidiary of F. Hoffmann-La Roche Ltd, got the approval for Tecentriq (atezolizumab) plus Cotellic (cobimetinib) and Zelboraf (vemurafenib). These drugs are used for the treatment of BRAF V600 mutation-positive advanced melanoma. The FDA approval is supported by results from the Phase 3 IMspire150 clinical trial done on peoples who suffered from advanced melanoma and previously untreated BRAF V600 mutation. The approval will support Roche to build a strong market for the Tecentriq/Cotellic combo. (Get 15% Discount on Buying this Report) A full Report of Melanoma Cancer Market is Available at: https://www.omrglobal.com/industry- reports/melanoma-cancer-market Moreover, in May 2020, SciBase, announced that it has received approval from the FDA for Nevisense 3.0, the third generation of their Nevisense system for early melanoma detection. Nevisence is an AI-based point-of-care system that is used for the non-invasive evaluation of irregular moles. Through this approval for the system to detect early melanoma cancer will support the company to expand its marketing and sales activities in the market. Thus, these approvals by FDA will impact positively the growth of the melanoma cancer market during the forecast period. To Request a Sample of our Market: https://www.omrglobal.com/request-sample/melanoma-cancer-market Report on Melanoma Cancer Market Coverage •The market number available for – 2020-2027 •Base year- 2020 •Forecast period- 2021-2027 Segment Covered- •By Diagnosis •By Therapy Regions Covered- •North America •Europe •Asia-Pacific •Rest of the World •Competitive Landscape- Bristol-Myers Squibb Co., GlaxoSmithKline plc, AstraZeneca PLC, Amgen Inc, Novartis AG, Abbott Laboratories, Johnson & Johnson Services, Inc., and others. Global Melanoma Cancer Market Segmentation By Diagnosis •Biopsy •Computed Tomography (CAT) Scan •Magnetic Resonance Imaging (MRI) •Positron Emission Tomography (PET) Scan By Therapy •Chemotherapy

  3. •Immunotherapy •Targeted Therapy •Radiation Therapy Regional Analysis North America •United States •Canada Europe •UK •Germany •Spain •France •Italy •Rest of Europe Asia-Pacific •China •India •Japan •South Korea •Rest of Asia-Pacific Rest of The World •Latin America •Middle East & Africa Company Profiles •Abbott Laboratories •Ab Sciences •AbbVie Inc. •Amgen, Inc. •AstraZeneca plc •Bristol-Myers Squibb Co. •Castle Biosciences, Inc. •Celgene Corp. •Chinook Therapeutics, Inc. •Daiichi Sankyo Co., Ltd. •ENB Therapeutics •Eisai Co Ltd. •F. Hoffman-La Roche Ltd. •GlaxoSmithKline PLC •Incyte Corp. •Iovance Biotherapeutics Inc. •Johnson & Johnson Services, Inc.

  4. •Merck & Co., Inc. •Novartis AG •Pierre Fabre S. A. •SciBase AB Reasons to Buying From us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/melanoma-cancer-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

More Related